Clinical Trial Update: Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial investigating volasertib with or without azacitidine in myelodysplastic syndromes; trial terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Volasertib (Volasertib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED | Results posted: 2018-08-09